KRRO Korro Bio Inc reports smaller than projected Q4 2025 loss shares rise nearly 7 percent on investor optimism
How Materion MTRN handles its debt maturity schedule Q1 2026 Earnings Beat Estimates
STEW SRH Total quarterly results lack key metrics as investors await updated fund performance data and market outlook
Aimco AIV Drifts Near 424 as Market Awaits Catalyst 20260521
Wells Fargo Reaches 110M Settlement Over Alleged Lending and Hiring Discrimination
Elon Musk Loses OpenAI Lawsuit But Legal Battles Likely to Continue
Short Sellers Target Fake AI Stocks as Tech Mania Creates Bearish Opportunities
Jim Cramer Highlights Equinix as a Strategic Data Center Investment Play
Oils Sudden Reversal Highlights Persistent Geopolitical Premium in Crude Markets
Shein Acquires Sustainable Brand Everlane in FastFashion Shakeup
Artha Venture Funds EarlyStage Strategy Spotting Winnable Ideas Before Market Readiness
Reddit Stock Slides Nearly 6 After Meta Launches Standalone Forum App
US Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Resilience
LKQ Q1 2026 Earnings EPS Misses Estimates by 245 as Stock Edges Higher
Essential Utilities Q1 2026 Earnings EPS Misses Analysts Expectations Despite Modest Stock Gain
XOMAP Q1 2026 Earnings Perpetual Preferred Faces Steep EPS Miss Amid Limited Revenue Visibility
RDZN Q1 2026 Earnings Significant EPS Miss Amidst Transition
OneSpan OSPN Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Execution
BCML Q1 2026 Earnings Strong EPS Surprise Driven by Net Interest Income and Credit Quality
Moolec Science Warrant MLECW Holds at Penny Levels as Declines Exceed 5
NCA Edges Lower Amidst Municipal Bond Headwinds Key Levels in Focus
Plum Acquisition Corp IV Unit PLMKU Holds Steady at 1088 as Market Awaits Catalyst
American Well Corporation AMWL Surges Over 4 Breaking Out or Bouncing Back
MMU Edges Higher in Modest Rally Municipal Bond Fund Shows Resilience
David Einhorns Hedge Fund Greenlight Capital Takes Bullish Stance on Major Mall Retail Stock
SCCE Q1 2026 Earnings Massive EPS Miss Signals Operational Challenges
Amylyx Pharmaceuticals AMLX Slips 25 as Biotech Sector Faces Renewed Scrutiny